financetom
Business
financetom
/
Business
/
Federal Trade Commission Invites Public to Disclose Experiences With Tech Platforms
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Federal Trade Commission Invites Public to Disclose Experiences With Tech Platforms
Feb 21, 2025 4:09 AM

06:45 AM EST, 02/21/2025 (MT Newswires) -- The Federal Trade Commission said Thursday it launched an effort to solicit public commentary to better understand how technology platforms "deny or degrade" access to services based on speech or affiliations.

The agency, now controlled by the administration of President Donald Trump, alleged the platforms "employ opaque or unpredictable internal procedures to restrict users' access to services" in what it suggests may constitute "anti-competitive conduct" or "potentially unlawful conduct."

The agency said it "encourages members of the public" to comment on relevant matters that may have affected them or others by May 21.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Meta Platforms Not Joining European Union AI Pact Immediately
Update: Meta Platforms Not Joining European Union AI Pact Immediately
Sep 26, 2024
06:09 AM EDT, 09/25/2024 (MT Newswires) -- (Updates with Meta's response in the last two paragraphs.) Meta Platforms ( META ) will not immediately join a European Union pact governing the development and implementation of AI but could do so at a later stage, multiple media outlets reported Tuesday, citing a company spokesperson. The pact is a measure to get...
2seventy Bio stops enrolling patients in blood cancer therapy study
2seventy Bio stops enrolling patients in blood cancer therapy study
Sep 26, 2024
Sept 25 (Reuters) - 2seventy bio on Wednesday said it would discontinue enrolling new patients in the late-stage study for its cell therapy to treat newly diagnosed myeloma, which is a type of blood cancer. (Reporting by Kashish Tandon in Bengaluru; Editing by Abinaya Vijayaraghavan) ...
Stellantis recalls over 15,000 Fiat vehicles in the US, NHTSA says
Stellantis recalls over 15,000 Fiat vehicles in the US, NHTSA says
Sep 26, 2024
(Reuters) - Stellantis ( STLA ) is recalling 15,835 Fiat vehicles due to a software error that may cause the front airbags to deploy with excessive force in a crash, the U.S. National Highway Traffic Safety Administration said on Wednesday. The recall includes some Fiat 124 Spider sports cars from model years 2017-2020. Dealers will update the airbag control module...
Obesity drug developer BioAge Labs targets to raise up to $200 mln in upsized US IPO
Obesity drug developer BioAge Labs targets to raise up to $200 mln in upsized US IPO
Sep 26, 2024
Sept 25 (Reuters) - Obesity drug developer BioAge Labs said on Wednesday it was seeking to raise as much as $199.5 million in its upsized initial public offering in the United States. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved